Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM: High-dose Oral Montelukast for Acute Asthma Exacerbations in Children
NCT05819541Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2023
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in status asthmaticus comparing High-dose oral montelukast plus standard treatment with Identical placebo plus standard treatment (2 arms). Primary endpoint: Montelukast plasma level at 4 hours. Started Oct 2023; status: completed.
02
Drugs
montelukast
03
Conditions
status asthmaticus
Beyond the preview
Go deeper on NCT05819541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05819541.